Physician-Assisted Suicide and Euthanasia Is Incompatible With Medicine: A Response From Medical Students.

e626 www.ccmjournal.org June 2017 • Volume 45 • Number 6 contact. Due to the high mortality in this cohort and high number of patients dying within 7 days of clinical deterioration, we additionally performed all analyses including a composite outcome of ARDS or death as well as a competing risk analysis where early mortality was modeled as the competing risk for ARDS. After accounting for the risk of hospital death, patients with a LIPS greater than or equal to 4 had a significant four-fold increased risk of developing ARDS (hazard ratio, 3.71; 95% CI, 2.05–6.72). Supported, in part, by National Center for Advancing Translational Sciences UL1 TR001073 (to Dr. Soto); National Heart, Lung, and Blood Institute (NHLBI) 3HL112855, R01 HL121232 (to Dr. Kor); NHLBI U01 HL108712-01 (to Drs. Kor, Park, Gajic, and Gong); NHLBI HL125119 (to Drs. Gajic and Gong); NHLBI HL122998 (to Drs. Park, Hou, and Gong); Brigham and Women’s Hospital Biomedical Research Institute Microgrant (to Dr. Shvilkina). Drs. Soto, Park, Hou, Kim, and Gong received support for article research from the National Institutes of Health. Dr. Kaufman received funding from UptoDate (royalties). Dr. Kim received support for article research from the Lupus Foundation; she received funding from Sloan Kettering and the Lupus Foundation; and she disclosed other support from EMD Serono (Data and Safety Monitoring Board board member) and Celgene (consultant for lupus trial). Dr. Gong’s institution received funding from the NHLBI. The remaining authors disclosed that they do not have any potential conflicts of interest.